Literature DB >> 25684792

Critical care series.

Joyce Generali1.   

Abstract

Entities:  

Year:  2015        PMID： 25684792      PMCID： PMC4321420          DOI： 10.1310/hpj5001-5

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


× No keyword cloud information.
  9 in total

1.  Adverse drug events in intensive care units: risk factors, impact, and the role of team care.

Authors:  Sandra L Kane-Gill; Judith Jacobi; Jeffrey M Rothschild
Journal:  Crit Care Med       Date:  2010-06       Impact factor: 7.598

2.  Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit.

Authors:  Sandra Kane-Gill; Rhonda S Rea; Margaret M Verrico; Robert J Weber
Journal:  Am J Health Syst Pharm       Date:  2006-10-01       Impact factor: 2.637

3.  Potential drug-drug interactions in cardiothoracic intensive care unit of a pulmonary teaching hospital.

Authors:  Behrooz Farzanegan; Maryam Alehashem; Marjan Bastani; Shadi Baniasadi
Journal:  J Clin Pharmacol       Date:  2014-12-05       Impact factor: 3.126

Review 4.  Outcome of adverse events and medical errors in the intensive care unit: a systematic review and meta-analysis.

Authors:  Adil H Ahmed; Jyothsna Giri; Rahul Kashyap; Balwinder Singh; Yue Dong; Oguz Kilickaya; Patricia J Erwin; M Hassan Murad; Brian W Pickering
Journal:  Am J Med Qual       Date:  2013-12-19       Impact factor: 1.852

5.  Analysis of risk factors for adverse drug events in critically ill patients*.

Authors:  Sandra L Kane-Gill; Levent Kirisci; Margaret M Verrico; Jeffrey M Rothschild
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

Review 6.  The impact of critical care pharmacists on enhancing patient outcomes.

Authors:  Sandra L Kane; Robert J Weber; Joseph F Dasta
Journal:  Intensive Care Med       Date:  2003-03-29       Impact factor: 17.440

7.  Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing ICU pharmacotherapy.

Authors:  Robert J Weber; Sandra L Kane; Vincent A Oriolo; Melissa Saul; Susan J Skledar; Joseph F Dasta
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

Review 8.  Pharmacist contributions as members of the multidisciplinary ICU team.

Authors:  Candice R Preslaski; Ishaq Lat; Robert MacLaren; Jason Poston
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

9.  Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.

Authors:  Robert MacLaren; C A Bond
Journal:  Pharmacotherapy       Date:  2009-07       Impact factor: 4.705
  9 in total
  1 in total

1.  Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis.

Authors:  Parvati B Patel; Tejas K Patel
Journal:  Eur J Clin Pharmacol       Date:  2019-06-11       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.